Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Author:
Robbiani Davide F.ORCID, Gaebler ChristianORCID, Muecksch FraukeORCID, Lorenzi Julio C. C.ORCID, Wang Zijun, Cho Alice, Agudelo Marianna, Barnes Christopher O., Gazumyan Anna, Finkin Shlomo, Hägglöf Thomas, Oliveira Thiago Y., Viant Charlotte, Hurley Arlene, Hoffmann Hans-Heinrich, Millard Katrina G., Kost Rhonda G., Cipolla Melissa, Gordon Kristie, Bianchini Filippo, Chen Spencer T., Ramos Victor, Patel Roshni, Dizon Juan, Shimeliovich Irina, Mendoza Pilar, Hartweger HaraldORCID, Nogueira Lilian, Pack Maggi, Horowitz Jill, Schmidt Fabian, Weisblum Yiska, Michailidis Eleftherios, Ashbrook Alison W.ORCID, Waltari Eric, Pak John E., Huey-Tubman Kathryn E., Koranda Nicholas, Hoffman Pauline R., West Anthony P., Rice Charles M., Hatziioannou Theodora, Bjorkman Pamela J.ORCID, Bieniasz Paul D., Caskey Marina, Nussenzweig Michel C.
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference47 articles.
1. Graham, R. L., Donaldson, E. F. & Baric, R. S. A decade after SARS: strategies for controlling emerging coronaviruses. Nat. Rev. Microbiol. 11, 836–848 (2013). 2. Gralinski, L. E. & Baric, R. S. Molecular pathology of emerging coronavirus infections. J. Pathol. 235, 185–195 (2015). 3. Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 (2020). 4. Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292 (2020). 5. Jiang, S., Hillyer, C. & Du, L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. 41, 355–359 (2020).
Cited by
1625 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|